Abstract
It has been shown previously that the level of soluble CD-2 determinants (E-receptors) is elevated in the serum of patients with various immunodeficiency states. The aim of the present preliminary study was to determine the level of soluble CD-2 in the sera of individuals infected with human immunodeficiency virus (HIV), in order to assess the contribution of soluble CD-2 molecules to the immunological deterioration of these patients. The serum CD-2 concentration was determined by an enzyme-linked immunosorbent assay, using a monoclonal CD-2 antibody. Considerable levels of CD-2 were detected in the sera of 15.9% of 63 normal controls tested, with a mean absorbance at 492 nm of 0.154 +/- 0.033. In contrast, in none of the 13 asymptomatic HIV-infected individuals tested could soluble CD-2 be detected (mean absorbance of 0.00093 +/- 0.0048). Elevated concentrations of CD-2 were found in the sera of 3 of 12 patients tested who were suffering from acquired immunodeficiency syndrome (AIDS). Thus, following HIV infection there is an initial phase of reduction of soluble CD-2, probably reflecting diminished T-cell activation. Thereafter, in some AIDS patients episodes of T-cell destruction seem to be correlated with the release of CD-2 molecules into the serum.
| Original language | English |
|---|---|
| Pages (from-to) | 347-351 |
| Number of pages | 5 |
| Journal | Cancer Detection and Prevention |
| Volume | 14 |
| Issue number | 3 |
| State | Published - 1990 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Changes in the level of soluble CD-2 molecules in the serum of HIV-infected individuals.'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver